Bristol Myers Squibb invests $2.3 billion in new Houston manufacturing campus

• Bristol Myers Squibb to build a modular, multi-modal manufacturing campus in Houston, Texas, investing about USD 2.3 billion.
• Site at Generation Park spans about 600,000 square feet, targeting drug product and finished-goods output from late development through launch.
• Campus designed to add or reconfigure capacity, supporting multiple modalities including small molecules, biologics, antibody-drug conjugates.
• Plan includes nearly 500 skilled jobs at start, with about 2,000 construction and indirect jobs expected during 2027-2030 buildout.
• Project ties to a USD 40 billion, five-year U.S. investment commitment across R&D, technology, domestic manufacturing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20260810766100) on August 10, 2026, and is solely responsible for the information contained therein.